166 related articles for article (PubMed ID: 23764501)
1. Geographic differences in approach to advanced gastric cancer: Is there a standard approach?
Kim R; Tan A; Choi M; El-Rayes BF
Crit Rev Oncol Hematol; 2013 Nov; 88(2):416-26. PubMed ID: 23764501
[TBL] [Abstract][Full Text] [Related]
2. Challenges in first line chemotherapy and targeted therapy in advanced gastric cancer.
Garrido M; Fonseca PJ; Vieitez JM; Frunza M; Lacave AJ
Expert Rev Anticancer Ther; 2014 Aug; 14(8):887-900. PubMed ID: 24953238
[TBL] [Abstract][Full Text] [Related]
3. Future perspectives for the development of chemotherapy for advanced gastric cancer: Japanese and global status.
Higuchi K; Tanabe S; Azuma M; Sasaki T; Ishido K; Koizumi W
Pathobiology; 2011; 78(6):334-42. PubMed ID: 22104205
[TBL] [Abstract][Full Text] [Related]
4. Current questions for the treatment of advanced gastric cancer.
Cervantes A; Roda D; Tarazona N; Roselló S; Pérez-Fidalgo JA
Cancer Treat Rev; 2013 Feb; 39(1):60-7. PubMed ID: 23102520
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive review of S-1 in the treatment of advanced gastric adenocarcinoma.
Blum M; Suzuki A; Ajani JA
Future Oncol; 2011 Jun; 7(6):715-26. PubMed ID: 21675835
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy options for gastric cancer.
Meyerhardt JA; Fuchs CS
Semin Radiat Oncol; 2002 Apr; 12(2):176-86. PubMed ID: 11979419
[TBL] [Abstract][Full Text] [Related]
7. Advancing pharmacological treatment options for advanced gastric cancer.
Sudo K; Yamada Y
Expert Opin Pharmacother; 2015; 16(15):2293-305. PubMed ID: 26359224
[TBL] [Abstract][Full Text] [Related]
8. Metastatic gastric cancer treatment: Second line and beyond.
Ghosn M; Tabchi S; Kourie HR; Tehfe M
World J Gastroenterol; 2016 Mar; 22(11):3069-77. PubMed ID: 27003986
[TBL] [Abstract][Full Text] [Related]
9. The role of chemotherapy in metastatic gastric cancer.
Pasini F; Fraccon AP; DE Manzoni G
Anticancer Res; 2011 Oct; 31(10):3543-54. PubMed ID: 21965776
[TBL] [Abstract][Full Text] [Related]
10. [Patient with stomach cancer with metastases. What is the value of chemotherapy?].
Wilke H; Stahl M; Vanhoefer U
MMW Fortschr Med; 2003 Nov; 145(48):39-42. PubMed ID: 14724998
[TBL] [Abstract][Full Text] [Related]
11. [Clinical development of S-1 (TS-1) for advanced gastric cancer].
Wasaburo K; Tanabe S; Higuchi K; Sasaki T; Nakayama N; Mihara S; Nakatani K; Nishimura K; Shimoda T; Azuma M; Katada C; Hanaoka N; Naruke A; Ryu T; Ishido K; Saigenji K
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():57-63. PubMed ID: 16897973
[TBL] [Abstract][Full Text] [Related]
12. [A recent trial of chemo-radiation with S-1 against gastric cancer].
Saikawa Y; Kiyota T; Nakamura R; Wada N; Yoshida M; Kubota T; Kumai K; Shigematsu N; Kubo A; Kitajima M
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():99-105. PubMed ID: 16897982
[TBL] [Abstract][Full Text] [Related]
13. Is there a role for second-line chemotherapy in advanced gastric cancer?
Wesolowski R; Lee C; Kim R
Lancet Oncol; 2009 Sep; 10(9):903-12. PubMed ID: 19717092
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of capecitabine/cisplatin chemotherapy after failure of all conventional therapies in patients with advanced gastric cancer].
Nishikawa K; Iwase K; Aono T; Yoshida H; Nomura M; Tamagawa H; Matsuda C; Deguchi T; Kawada J; Higashi S; Umeda S; Deguchi K; Fushimi H; Takagi M; Fukui A; Tanaka Y
Gan To Kagaku Ryoho; 2013 Jan; 40(1):57-60. PubMed ID: 23306918
[TBL] [Abstract][Full Text] [Related]
15. [The effectiveness of S-1 based sequential chemotherapy as second-line treatment for advanced/recurrent gastric cancer].
Sugimoto N; Narahara H; Sakai D; Yamamoto S; Fumoto S; Yagi T; Imamura F; Iishi H; Tatsuta M
Gan To Kagaku Ryoho; 2009 Mar; 36(3):417-24. PubMed ID: 19295265
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy beyond second-line in advanced gastric cancer.
Kim SM; Park SH
World J Gastroenterol; 2015 Aug; 21(29):8811-6. PubMed ID: 26269670
[TBL] [Abstract][Full Text] [Related]
17. What is the reference cytotoxic regimen for advanced gastric cancer: standard versus optimal therapy?
Sohal DP; Sun W
Expert Rev Anticancer Ther; 2011 Dec; 11(12):1843-50. PubMed ID: 22117152
[TBL] [Abstract][Full Text] [Related]
18. Docetaxel monotherapy as a second-line treatment after failure of fluoropyrimidine and platinum in advanced gastric cancer: experience of 154 patients with prognostic factor analysis.
Jo JC; Lee JL; Ryu MH; Sym SJ; Lee SS; Chang HM; Kim TW; Lee JS; Kang YK
Jpn J Clin Oncol; 2007 Dec; 37(12):936-41. PubMed ID: 18211985
[TBL] [Abstract][Full Text] [Related]
19. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group.
Van Cutsem E; Van de Velde C; Roth A; Lordick F; Köhne CH; Cascinu S; Aapro M;
Eur J Cancer; 2008 Jan; 44(2):182-94. PubMed ID: 18093827
[TBL] [Abstract][Full Text] [Related]
20. Medical therapy of advanced malignant epithelial tumours of the ovary.
Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
